Bridger Management Bearish on These 5 Stocks in Third Quarter

Wall St. Watchdog reveals information regarding significant reduction in shares for Bridger Management’s holdings on the quarter ending September 30th, 2011. The firm is bearish on these stocks:

  • Popular Inc. (NASDAQ:BPOP): On 06/30/2011, Bridger Management reported holding 17,881,481 shares. On 09/30/2011, Bridger Management reported holding 5,570,248 shares. The net reduction in shares for this position is 12,311,233 or 68.85%. About Company: Popular, Inc. is a bank holding company that provides commercial banking services through branches in Puerto Rico, the British Virgin Islands, the Dominican Republic, and the United States mainland. The Company also provides mortgage and consumer finance, lease financing, investment banking and broker/dealer activities, retail financial services, and automated tellers.
  • Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD): On 06/30/2011, Bridger Management reported holding 2,500,000 shares. On 09/30/2011, Bridger Management reported holding 1,879,375 shares. The net reduction in shares for this position is 620,625 or 24.83%. About Company: Ironwood Pharmaceuticals, Inc. is a pharmaceutical company. The Company discovers, develops, manufactures, and commercializes marketed drugs. Ironwood products used in treatments of cholesterol, gastrointestinal and cardiovascular diseases, pain, inflammation, and others.
  • Corcept Therapeutics Inc. (NASDAQ:CORT): On 06/30/2011, Bridger Management reported holding 635,100 shares. On 09/30/2011, Bridger Management reported holding 559,218 shares. The net reduction in shares for this position is 75,882 or 11.95%. About Company: Corcept Therapeutics Inc. is a pharmaceutical company that discovers and develops drugs for the treatment of severe metabolic and psychiatric disorders. The Company’s lead product modulates the effect of cortisol, also known as the “stress hormone”, by selectively blocking the binding of cortisol to one of its two known receptors, the GR-II receptor.
  • Onyx Pharmaceuticals Inc. (NASDAQ:ONXX): On 06/30/2011, Bridger Management reported holding 1,100,000 shares. On 09/30/2011, Bridger Management reported holding 1,075,000 shares. The net reduction in shares for this position is 25,000 or 2.27%. About Company: Onyx Pharmaceuticals, Inc. discovers and develops novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company focuses on defining the function of certain mutated genes which are known to cause cancer, and on developing therapies to reverse the effects of the mutation or to kill the cancer cell.
  • Amicus Therapeutics Inc. (NASDAQ:FOLD): On 06/30/2011, Bridger Management reported holding 984,982 shares. On 09/30/2011, Bridger Management reported holding 982,466 shares. The net reduction in shares for this position is 2,516 or 0.26%. About Company: Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

(Note: Data regarding Bridger Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>